Search research articles
Contact Us
Filters
Showing results (161-170 of 263) with videos related to
Page
of 27
Sort By:
The American Journal of Surgical Pathology
|
December 9, 2021
Papillary Renal Cell Carcinoma With Microcystic Architecture Is Strongly Associated With Extrarenal Invasion and Metastatic Disease
Emily Chan, Bradley A Stohr, Robert S Butler, et al.
Investigational New Drugs
|
March 19, 2021
Vorolanib (X-82), an oral anti-VEGFR/PDGFR/CSF1R tyrosine kinase inhibitor, with everolimus in solid tumors: results of a phase I study
Katrina S Pedersen, Patrick M Grierson, Joel Picus, et al.
Journal of Innate Immunity
|
October 1, 2023
Emerging Roles of cGAS-STING Signaling in Mediating Ocular Inflammation
Linbin Zhou, Bo Man Ho, Hoi Ying Emily Chan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 24, 2016
Phase I trial of vorinostat added to chemoradiation with capecitabine in pancreatic cancer
Emily Chan, Lori R Arlinghaus, Dana B Cardin, et al.
The American Journal of Surgical Pathology
|
June 13, 2025
Serous Borderline Tumors of the Testis and Paratestis: A Clinicopathologic Study of 19 Tumors Emphasizing Morphologic Spectrum and Clinical Outcome
Ali Shahabi, Aleksei Konstantinov, Jesse K McKenney, et al.
The Prostate
|
September 19, 2022
Time to second biochemical recurrence as a prognostic indicator in postprostatectomy patients who undergo salvage radiation therapy: An RTOG 9601 based post hoc analysis
Emily Chan Brodowsky, Akshay Sood, Mohit Butaney, et al.
Cancer Chemotherapy and Pharmacology
|
September 4, 2012
Phase I and pharmacokinetic study of IHL-305 (PEGylated liposomal irinotecan) in patients with advanced solid tumors
Jeffrey R Infante, Vicki L Keedy, Suzanne F Jones, et al.
Cell Reports
|
August 16, 2018
Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation
Ryan Raisner, Samir Kharbanda, Lingyan Jin, et al.
Clinical Colorectal Cancer
|
May 22, 2026
Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal Cancer
Lisa Salvatore, Marwan Fakih, Yasutoshi Kuboki, et al.
Cancer Discovery
|
December 12, 2012
Noncovalent wild-type-sparing inhibitors of EGFR T790M
Ho-June Lee, Gabriele Schaefer, Timothy P Heffron, et al.
Page
of 27
Search research articles
Search
Showing results (161-170 of 263) with videos related to
Sort By:
Page
of 27
The American Journal of Surgical Pathology
|
December 9, 2021
Papillary Renal Cell Carcinoma With Microcystic Architecture Is Strongly Associated With Extrarenal Invasion and Metastatic Disease
Emily Chan, Bradley A Stohr, Robert S Butler, et al.
Investigational New Drugs
|
March 19, 2021
Vorolanib (X-82), an oral anti-VEGFR/PDGFR/CSF1R tyrosine kinase inhibitor, with everolimus in solid tumors: results of a phase I study
Katrina S Pedersen, Patrick M Grierson, Joel Picus, et al.
Journal of Innate Immunity
|
October 1, 2023
Emerging Roles of cGAS-STING Signaling in Mediating Ocular Inflammation
Linbin Zhou, Bo Man Ho, Hoi Ying Emily Chan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 24, 2016
Phase I trial of vorinostat added to chemoradiation with capecitabine in pancreatic cancer
Emily Chan, Lori R Arlinghaus, Dana B Cardin, et al.
The American Journal of Surgical Pathology
|
June 13, 2025
Serous Borderline Tumors of the Testis and Paratestis: A Clinicopathologic Study of 19 Tumors Emphasizing Morphologic Spectrum and Clinical Outcome
Ali Shahabi, Aleksei Konstantinov, Jesse K McKenney, et al.
The Prostate
|
September 19, 2022
Time to second biochemical recurrence as a prognostic indicator in postprostatectomy patients who undergo salvage radiation therapy: An RTOG 9601 based post hoc analysis
Emily Chan Brodowsky, Akshay Sood, Mohit Butaney, et al.
Cancer Chemotherapy and Pharmacology
|
September 4, 2012
Phase I and pharmacokinetic study of IHL-305 (PEGylated liposomal irinotecan) in patients with advanced solid tumors
Jeffrey R Infante, Vicki L Keedy, Suzanne F Jones, et al.
Cell Reports
|
August 16, 2018
Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation
Ryan Raisner, Samir Kharbanda, Lingyan Jin, et al.
Clinical Colorectal Cancer
|
May 22, 2026
Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal Cancer
Lisa Salvatore, Marwan Fakih, Yasutoshi Kuboki, et al.
Cancer Discovery
|
December 12, 2012
Noncovalent wild-type-sparing inhibitors of EGFR T790M
Ho-June Lee, Gabriele Schaefer, Timothy P Heffron, et al.
Page
of 27